Rocket Pharmaceuticals Inc (RCKT)
23.46
+0.67
(+2.94%)
USD |
NASDAQ |
May 03, 16:00
23.46
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Price to Book Value: 4.311 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 4.187 |
| May 01, 2024 | 4.140 |
| April 30, 2024 | 3.954 |
| April 29, 2024 | 4.015 |
| April 26, 2024 | 4.038 |
| April 25, 2024 | 4.061 |
| April 24, 2024 | 4.342 |
| April 23, 2024 | 4.349 |
| April 22, 2024 | 4.386 |
| April 19, 2024 | 4.189 |
| April 18, 2024 | 4.314 |
| April 17, 2024 | 4.351 |
| April 16, 2024 | 4.456 |
| April 15, 2024 | 4.412 |
| April 12, 2024 | 4.445 |
| April 11, 2024 | 4.645 |
| April 10, 2024 | 4.487 |
| April 09, 2024 | 4.658 |
| April 08, 2024 | 4.481 |
| April 05, 2024 | 4.595 |
| April 04, 2024 | 4.590 |
| April 03, 2024 | 4.672 |
| April 02, 2024 | 4.722 |
| April 01, 2024 | 4.910 |
| March 28, 2024 | 4.950 |
| Date | Value |
|---|---|
| March 27, 2024 | 5.007 |
| March 26, 2024 | 4.880 |
| March 25, 2024 | 4.942 |
| March 22, 2024 | 5.000 |
| March 21, 2024 | 5.091 |
| March 20, 2024 | 5.119 |
| March 19, 2024 | 4.937 |
| March 18, 2024 | 4.873 |
| March 15, 2024 | 4.926 |
| March 14, 2024 | 5.012 |
| March 13, 2024 | 5.174 |
| March 12, 2024 | 4.972 |
| March 11, 2024 | 5.071 |
| March 08, 2024 | 5.121 |
| March 07, 2024 | 5.056 |
| March 06, 2024 | 5.102 |
| March 05, 2024 | 5.062 |
| March 04, 2024 | 5.275 |
| March 01, 2024 | 5.610 |
| February 29, 2024 | 5.384 |
| February 28, 2024 | 5.334 |
| February 27, 2024 | 5.648 |
| February 26, 2024 | 5.474 |
| February 23, 2024 | 5.380 |
| February 22, 2024 | 5.328 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.255
Minimum
May 11 2022
14.78
Maximum
Dec 22 2020
4.113
Average
3.794
Median
Nov 27 2023
Price to Book Value Benchmarks
| ADMA Biologics Inc | 11.48 |
| Geron Corp | 8.644 |
| Madrigal Pharmaceuticals Inc | 11.27 |
| Ligand Pharmaceuticals Inc | 1.867 |
| Puma Biotechnology Inc | 4.397 |
Price to Book Value Related Metrics
| Price | 23.46 |
| Earnings Yield | -12.53% |
| Market Cap | 2.123B |